Adaptive Biotechnologies Corp Ratios

Ratios Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 56.40%56.01%54.80%37.63%38.15%48.41%47.98%52.64%
EBT Margin -111.40%-83.44%-80.65%-148.63%-134.31%-108.13%-132.32%-89.18%
EBIT Margin -115.68%-89.39%-92.15%-155.33%-135.39%-108.03%-133.33%-90.83%
EBITDA Margin -115.68%-89.39%-92.15%-155.33%-135.39%-108.03%-133.33%-90.83%
Operating Margin -115.68%-89.39%-92.15%-155.33%-135.39%-108.03%-133.33%-90.83%
Net Margin -111.05%-83.26%-81.78%-148.63%-134.30%-108.13%-132.32%-89.18%
FCF Margin -96.96%-69.27%228.28%-171.26%-164.87%-108.09%-98.09%-55.25%
Efficiency
Inventory Average 8.45M11.57M16.66M16.86M14.45M11.44M
Assets Average 622.50M1,014.36M1,019.88M889.98M758.88M600.25M
Equity Average 156.46M657.15M673.68M534.13M386.28M255.55M
Invested Capital -258.11M571.04M743.27M604.10M464.17M308.40M203.57M
Asset Utilization Ratio 0.140.100.150.210.220.30
Leverage & Solvency
Interest Coverage Ratio -47.24-16.45-14.04
Debt to Equity 0.270.420.66
Debt Ratio 0.150.200.25
Equity Ratio -0.780.630.670.650.540.470.38
Times Interest Earned -47.24-16.45-14.04
Valuation
Enterprise Value -165.02M3,143.36M7,399.08M3,607.21M594.35M362.86M662.22M
Market Capitalization 3,720.22M8,087.35M3,960.16M1,092.61M709.39M884.74M
Return Ratios
Return on Sales -1.11%-0.83%-0.81%-1.49%-1.34%-1.08%-1.32%-0.89%
Return on Capital Employed -0.14%-0.17%-0.23%-0.26%-0.34%-0.32%
Return on Assets -0.11%-0.14%-0.20%-0.23%-0.30%-0.27%
Return on Equity -0.44%-0.22%-0.31%-0.38%-0.58%-0.62%